8th May 2001
Of mice and men - First phase of mouse genome sequencing project completed
Publicly Available Data Expected to Speed Medical Discovery
The Mouse Sequencing Consortium (MSC), announced today (Tuesday 8th May) that it has completed the first phase of reading the mouse 'book of life', reaching its goal on time and within budget.
The $58 million (£40 million) collaboration on the mouse genome was initiated in October 2000 and has taken just 6 months to generate '3x' coverage - where each of the 3 billion 'letters' of the genome is 'read' three times. The sequence now covers an estimated 94% of the mouse genome.
The MSC is a collaboration between public and private organizations--the US National Institutes of Health, the Wellcome Trust and three private companies--Glaxo SmithKline, the Merck Genome Research Institute and Affymetrix, Inc.
Dr Mike Dexter, Director of the Wellcome Trust, said: "This represents a landmark on a journey that will allow researchers all over the world to create new models of disease and to test potential therapies. Congratulations to the scientists at the Wellcome Trust Sanger Centre, who have made the British contribution to the mouse sequencing project. Yet again, the collaborative effort of scientists, supported by government, industry and the Trust, has been rapidly rewarded, and the success of the project suggests that such collaborations should be a model for the future."
Mice are one of the most widely used animal models for diseases, and knowledge of the mouse genome will allow researchers to study the functions of genes in health and illness, and test the effectiveness of novel therapies. Comparison of DNA sequences from mice and humans--two genetically similar animals--will also help researchers interpret human genome data, allowing them to identify previously unrecognised genes and regions that control their activity.
"This is a great day for finding genes in the human," says Francis S. Collins, M.D., Ph.D., director of the National Human Genome Research Institute. "Comparing mouse sequence to human sequence will help identify previously unknown human genes. This is essentially using evolution's "lab notebook" to understand how the genome works. Now we need to finish the work so the mouse sequence is as accurate and complete as the human sequence."
As with the public Human Genome Project, the MSC is committed to finishing the mouse genome sequence. Throughout both projects, the data have been made freely available without restriction to researchers across the world.
Notes to Editors:
- Researchers at the Wellcome Trust Genome Campus in Cambridgeshire, funded by the Trust and the
European Molecular Biology Laboratory (EMBL), have developed new tools to provide access to the sequence of the mouse
and to align mouse genes with genes in the human sequence announced in June
2000.
- The Trust has invested £8 million to set up and run Ensembl, which is
managed jointly by the Wellcome Trust's Sanger Centre and the European Bioinformatics Institute (whose parent
organisation, the European Molecular Biology Laboratory, also provides some
Ensembl support). The Trust also funded the UK contribution to the Human Genome
Project with £210 million.
- Members of the Mouse Sequencing Consortium and their contributions to the effort are
- Glaxo SmithKline ($6.5 million),
- the Merck Genome Research Institute ($6.5 million),
- Affymetrix, Inc. ($3.5 million),
- the Wellcome Trust ($7.75 million), and
- six institutes of the National Institutes of Health ($34 million), including
-
- the National Cancer Institute,
- the National Human Genome Research Institute,
- the National Institute on Deafness and Other Communication Disorders,
- the National Institute of Diabetes and Digestive and Kidney Disease,
- the National Institute of Neurological Disorders and Stroke, and
- the National Institute of Mental Health.
- The DNA sequencing work was conducted at
- The Wellcome Trust Sanger Centre in Cambridgeshire,
- The Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, and
-
Washington University School of Medicine in St. Louis.
- The mouse sequence data can be found in either of two public databases:
- The Ensembl Trace Server can be found at http://trace.ensembl.org. Ensembl is a joint project between The European Bioinformatics Institute (EBI) and the Wellcome Trust Sanger Centre to develop a software system that produces and maintains automatic annotation on eukaryotic genomes.
- The Trace Archive, a newly-established public database operated by the U.S. National Centre for Biotechnology
Information, which can be found at http://www.ncbi.nlm.nih.gov/Traces/trace.cgi
- The Wellcome Trust is an independent, research-funding charity,
established under the will of Sir Henry Wellcome in 1936. It is funded from a private endowment, which is managed with
long-term stability and growth in mind. The Trust's mission is to foster and promote research with the aim of improving
human and animal health.
- The public human data are available at:
-
- Ensembl - www.ensembl.org/
- European sequence database - www.ebi.ac.uk/
- Genbank (United States) - www.ncbi.nlm.nih.gov/
- DNA Databank (Japan) - www.ddbj.nig.ac.jp/
- The Sanger Centre - www.sanger.ac.uk/
- The European Bioinformatics Institute - www.ebi.ac.uk/
For more information contact:
Don Powell The Wellcome Trust Sanger Centre (01223) 494956; Mobile: (0788) 4188243 don@sanger.ac.uk Shaun Griffin Wellcome Trust (020) 7611 8612 s.griffin@wellcome.ac.uk Mary Prescott The Mouse Sequencing Consortium 001-312-397-6604 mprescott@bsmg.com Rick Koenig Glaxo Smith Kline 001-610-270-5546 Rick_M_Koenig@sbphrd.com Kathryn Munoz Merck Genome Research Institute 001-908-423-6492 kathryn_munoz@merck.com Affymetrix, Inc. Anne Bowdidge 001-408-731-5925 anne_bowdidge@affymetrix.com Larry Thompson National Human Genome Research Institute 001-301-594-0954 thompsl@mail.nih.gov
